- Type / Class
- Equity / Common Stock
- Shares outstanding
- 1,236,593,901
- Total 13F shares
- 978,374,690
- Share change
- +4,253,503
- Total reported value
- $69,232,836,215
- Put/Call ratio
- 134%
- Price per share
- $70.78
- Number of holders
- 1,514
- Value change
- +$313,533,710
- Number of buys
- 672
- Number of sells
- 749
Quarterly Holders Quick Answers
What is CUSIP 375558103?
CUSIP 375558103 identifies GILD - GILEAD SCIENCES, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 375558103:
Top shareholders of GILD - GILEAD SCIENCES, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
8.3%
|
102,969,463
|
$6,993,686,000 | — | 31 Mar 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.3%
|
90,693,263
|
$6,159,886,000 | — | 31 Mar 2017 | |
| STATE STREET CORP |
13F
|
Company |
4.9%
|
60,006,200
|
$4,075,620,000 | — | 31 Mar 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
2.5%
|
30,570,798
|
$2,076,368,000 | — | 31 Mar 2017 | |
| FMR LLC |
13F
|
Company |
1.8%
|
22,779,298
|
$1,547,170,000 | — | 31 Mar 2017 | |
| Capital Research Global Investors |
13F
|
Company |
1.7%
|
21,474,531
|
$1,458,550,000 | — | 31 Mar 2017 | |
| Invesco Ltd. |
13F
|
Company |
1.5%
|
18,153,295
|
$1,232,969,000 | — | 31 Mar 2017 | |
| PARNASSUS INVESTMENTS, LLC |
13F
|
Company |
1.4%
|
16,726,150
|
$1,110,228,000 | — | 31 Mar 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.3%
|
16,313,696
|
$1,108,027,000 | — | 31 Mar 2017 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
1.2%
|
14,444,216
|
$981,051,000 | — | 31 Mar 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
14,417,098
|
$977,973,000 | — | 31 Mar 2017 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.2%
|
14,379,174
|
$976,594,000 | — | 31 Mar 2017 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
13,298,648
|
$903,245,000 | — | 31 Mar 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
13,188,786
|
$895,782,000 | — | 31 Mar 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1%
|
12,919,948
|
$877,522,000 | — | 31 Mar 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.99%
|
12,190,392
|
$827,962,000 | — | 31 Mar 2017 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.95%
|
11,742,836
|
$797,574,000 | — | 31 Mar 2017 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.93%
|
11,496,442
|
$780,838,000 | — | 31 Mar 2017 | |
| Capital World Investors |
13F
|
Company |
0.9%
|
11,074,749
|
$752,197,000 | — | 31 Mar 2017 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.87%
|
10,772,951
|
$731,699,000 | — | 31 Mar 2017 | |
| Boston Partners |
13F
|
Company |
0.83%
|
10,217,997
|
$694,007,000 | — | 31 Mar 2017 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.82%
|
10,085,127
|
$684,982,000 | — | 31 Mar 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.73%
|
9,053,923
|
$614,942,000 | — | 31 Mar 2017 | |
| MORGAN STANLEY |
13F
|
Company |
0.7%
|
8,605,703
|
$584,499,000 | — | 31 Mar 2017 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.62%
|
7,707,248
|
$523,476,000 | — | 31 Mar 2017 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.52%
|
6,444,425
|
$437,705,000 | — | 31 Mar 2017 | |
| Legal & General Group Plc |
13F
|
Company |
0.52%
|
6,407,463
|
$435,194,000 | — | 31 Mar 2017 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.52%
|
6,383,688
|
$433,580,000 | — | 31 Mar 2017 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.51%
|
6,292,805
|
$427,407,317 | — | 31 Mar 2017 | |
| Capital International Investors |
13F
|
Company |
0.49%
|
6,010,050
|
$408,203,000 | — | 31 Mar 2017 | |
| APG Asset Management N.V. |
13F
|
Company |
0.48%
|
5,923,426
|
$402,319,000 | — | 31 Mar 2017 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.48%
|
5,887,973
|
$399,911,000 | — | 31 Mar 2017 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.47%
|
5,758,011
|
$391,084,000 | — | 31 Mar 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.46%
|
5,678,575
|
$385,689,000 | — | 31 Mar 2017 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.42%
|
5,213,046
|
$354,070,000 | — | 31 Mar 2017 | |
| UBS Group AG |
13F
|
Company |
0.4%
|
4,930,154
|
$334,855,000 | — | 31 Mar 2017 | |
| Swiss National Bank |
13F
|
Company |
0.38%
|
4,668,124
|
$317,059,000 | — | 31 Mar 2017 | |
| BARCLAYS PLC |
13F
|
Company |
0.36%
|
4,463,679
|
$303,172,000 | — | 31 Mar 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.36%
|
4,404,045
|
$299,123,000 | — | 31 Mar 2017 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.33%
|
4,140,707
|
$281,236,000 | — | 31 Mar 2017 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.33%
|
4,128,736
|
$280,423,000 | — | 31 Mar 2017 | |
| AJO, LP |
13F
|
Company |
0.33%
|
4,114,151
|
$279,433,000 | — | 31 Mar 2017 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.33%
|
4,021,538
|
$273,143,000 | — | 31 Mar 2017 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.32%
|
3,994,431
|
$271,302,000 | — | 31 Mar 2017 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.32%
|
3,977,029
|
$270,120,000 | — | 31 Mar 2017 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.31%
|
3,781,104
|
$256,813,000 | — | 31 Mar 2017 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.3%
|
3,656,251
|
$248,332,000 | — | 31 Mar 2017 | |
| AXA S.A. |
13F
|
Company |
0.3%
|
3,652,261
|
$248,062,000 | — | 31 Mar 2017 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.29%
|
3,626,170
|
$246,247,000 | — | 31 Mar 2017 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.29%
|
3,632,064
|
$245,273,000 | — | 31 Mar 2017 |
Institutional Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q2 2017
As of 30 Jun 2017,
GILEAD SCIENCES, INC. - Common Stock (GILD) was held by
1,514 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
978,374,690 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Bank of New York Mellon Corp, FMR LLC, PARNASSUS INVESTMENTS /CA, Capital Research Global Investors, Invesco Ltd., NORTHERN TRUST CORP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
1,516
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
1,515
Q2 2017 holders
1,514
Holder diff
-1
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 Value $ | Q2 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.